CCL2 and neoplasm: Neutralization of the chemokine CCL2 or inhibition of colony-stimulating factor-1 (CSF-1) receptor signaling prevent monocyte infiltration into the lymph node or tumor lesions, with a consequent reduced recruitment of tumor-specific T cells and damped antitumor responses [265].